Thursday, 17 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14422
Articles
Company
Drug
RemeGen’s Telitacicept Shows Positive Results in Phase II Myasthenia Gravis Study
February 1, 2025
Company
Deals
Immunochina Pharmaceuticals Raises Funds for Gene Therapy Development
February 1, 2025
Company
Medical Device
BGI Genomics Receives NMPA Approval for Chromosome Aneuploidy Detection Kit
February 1, 2025
Company
Policy / Regulatory
NMPA Suspends GSK’s Avodart Amid Inspection Findings
February 1, 2025
Company
Drug
Antengene’s ATG-017 Gets FDA Approval for Phase I Clinical Study
February 1, 2025
Company
Drug
China Grand’s STC3141 Reaches Primary Endpoint in ARDS Phase Ib Study
February 1, 2025
Company
Allogene Overland Biopharm Completes State-of-the-Art AlloCAR T Facility in Shanghai
February 1, 2025
Company
Deals
Shandong Buchang Partners with REMD Bio for Bispecific Antibody Development
February 1, 2025
Company
Deals
Eucure Biopharma Partners with ISU ABXIS to Develop Tri-Specific Antibodies Using YH003
February 1, 2025
Company
Drug
Zhejiang Medicine’s ARX788 Advances to Phase II Study for HER2-Positive Cholangiocarcinoma
February 1, 2025
Company
Drug
Simcere’s SIM0235 Begins US Phase I Trial for Anti-Tumor Therapy
February 1, 2025
Policy / Regulatory
China’s National Plan to Combat Microbial Drug Resistance Released
February 2, 2025
1
2
…
1,105
1,106
1,107
1,108
1,109
…
1,201
1,202
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?